Læknablaðið : fylgirit - 01.08.2002, Page 5

PROGRAM / 21 ST NORDIC CONGRESS OF ALLERGOLOGY
09:50 - 10:25 The issue is Microbial Stiniulation
Prof. Bengt Björkstén, SE
10:25 -10:45 Discussion
10:45-11:15 Coffee Break
11:15-11:45 Pediatric Asthma
Prof. Hans Bisgaard, DK
11:45 -12:15 Compliancc in childhood asthma
Dr. Gunnar Jónasson, IS
12:15 -13:45 The Ice Cube Run by the invitation of GSK, registration at the GSK stand
12:15 -13:45 Lunch at Sunnusalur, Radisson SAS Saga Hotel
13:45 -15:00
13:45-14:10
14:10-14:35
14:35 -14:45
14:45 -15:00
Syniposium GlaxoSmithkline: Airway reniodelling
Chairman: Prof. William W. Busse, US
Airivay Remodelling in Asthma: What is its importance?
Prof. William W. Busse, US
Airvvay smooth niuscle - an active immunological organ
Dr. Hákon Hákonarson, IS
Is asthma severity genetically determined?
Dr. Unnur Steina Björnsdóttir, IS
Discussion
Don 't forget your running shoes!!!
The lce Cube Run
As well as you all are invited you to join us in the 21 st Nordic Congress of Allergology in Reykjavik, lceland 21-24 of
August 2002, you are also invited to participate in the lce Cube Run.
The lce Cube Run is to be held on Thursday 22nd during the lunch break. The lce Cube Run is about 5 km long
and is located at the impressive west part of Reykjavik area. The course is all on flat paths. It starts outside the
Congress and Cultural Center of the University of lceland (Háskólabíó) and then leads out to the sea-side and into the
small and charming creek, Skerjafjöröur. The path returns back to the starting point and three lucky runners will get
special lce Cube prices.
You choose whether you run or walk. The important thing here is to take time out to join in this fun event. Come
individually or join up with your colleagues to make a team.
It's á great opportunity to get to know Reykjavik a little better and
improve your health at the same time!
The lce Cube Run is organized and sponsored by GlaxoSmithKline.
Registration and all further information at the GlaxoSmithKline stand at
the exhibition area.
Wc
GlaxoSmithKline
Læknaislaðið/Fylgirit 46 2002/88 5